Trainee (Diabetes, Obesity and Cardiometabolic Therapies - Development and Innovation)
Selection procedure reference: EMA/TR/11357
Deadline for applications: 06 May 2026 23:59 CET
The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.
This traineeship opportunity is now open for applications until 06 May 2026 23:59 CET, with an intake on 1 October 2026.
About the traineeship programme
The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Master's students (who posses a previous degree), who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.
Placement description
We are looking for a trainee in the Therapies for endocrine and cardiovascular diseases Service.
Specific objectives and projects
- Contribute to the strategic analysis and mapping of topics in the diabetes, obesity and broader cardiometabolic space, contributing to the development of innovative proposals and strategies
- Contribute to stakeholder initiatives
- Contribute to the preparation and coordination of meetings, ensuring effective collaboration between assessors, rapporteurs and stakeholders
- Prepare briefing documents and reports supporting decision-making and regulatory approaches
- Contribute to the development of a scientific knowledge platform by analysing assessment documents and proposing improvements to its structure, accessibility and usability
Learning outcomes
Eligibility criteria
To be eligible for consideration for this placement, you are required to:
- enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;
- possess a university degree in Pharmacy, Medicine or Life Science (minimum of three years or more) that must have been obtained between 6 May 2025 and 6 May 2026 or be a university student on an Erasmus + or a similar programme or a PhD student or a Master's student with a previous fully finished degree in the areas mentioned before.
- a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the Common European Framework for Languages
For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.
Additional skills
Project Management Skills: Ability to manage and coordinate projects effectively, ensuring timely delivery of outcomes ; Cross-Agency Collaboration: Strong collaborative skills to foster partnerships and communication between different stakeholders ; Research and Analysis: Proficiency in conducting research ; Demonstrated interest in using IT applications, with strong proficiency in Word, Excel, and PowerPoint to support analysis, reporting, and presentation tasks ; Communication skills: Ability to prepare, present, and communicate clearly complex matters ; Regulatory Knowledge: basic understanding of the centralised procedure ; Attention to Detail: Keen attention to detail to ensure accuracy and completeness in documentation and presentations.
Behavioural Competencies
You will demonstrate the following behavioural competencies:
- Communication skills
- Interpersonal skills
- Working with others
- Adaptability
- Research and analytical skills
- Learning and development
Conditions of traineeship
The traineeship is offered for 10 months (1 October 2026 – 31 July 2027) and takes place at the Agency’s premises in Amsterdam with possibility for teleworking up to 40% of working time from The Netherlands and occasional teleworking from outside The Netherlands. Traineeships are offered for either full-time or part-time (80% or 50%) if combined with university studies.
The Agency pays a monthly stipend of €2,049.77 for a full-time traineeship (reduced accordingly for 80% or 50%) and a travel contribution upon joining the Agency.
Each trainee will have a mentor at the Agency who will guide the trainee through the programme.
The conditions of employment are stated in the Executive Decision on rules governing the traineeship programme at the EMA available here.
Expected selection timelines
| Deadline for applications | 06 May 2026 23:59 CET |
|---|---|
| Assessments (remote) | From mid-June 2026 to mid-July 2026 |
| Decision and offers | By end of July 2026 |
| Placement start | 1 October 2026 |
______________________________________________________________________________________________________
Domenico Scarlattilaan 6 - 1083 HS Amsterdam - The Netherlands
Telephone +31 (0)88 781 6000 - Email recruitment@ema.europa.eu
© European Medicines Agency, 2024. Reproduction is authorised provided the source is acknowledged.
Job Segment:
Special Medicine, Diabetes, Endocrinology, Cardiac, Law, Healthcare, Legal